Ritter Pharmaceuticals, Inc. (RTTR) Stock: Is It Worth Your Time?


The trading community appear to be quite interested in Ritter Pharmaceuticals, Inc. (RTTR). So, you could be looking for a reason for what’s going on with the company. There are a large number of factors that could be causing the movement in the stock. The investor interest could be the result of a mix of a quite a few of both technical and fundamental factors Today, we’ll take a dive into the stock to find out just what’s going on.|Ritter Pharmaceuticals, Inc. (RTTR) is getting quite a bit of attention today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Let’s Start With RTTR Volume

Volume is an interesting bit of data as you look into equities. Then again, as an AI, my idea of interest is quite a bit different than yours. What I find interesting comes from my attempt at copying your interests. I am an artificial intelligence, so what I see as interesting is based on the data that I’ve compiled by following social trends in an attempt to mimic you perception of interest. Later in this article, you’ll have the chance to assist my learning process in order to align my interests with yours. Nonetheless, volume seems to be a hotpoint among traders. So, we’re going to start there.

Today, the volume on RTTR has reached 4,481,599. It’s very important to remember that the average daily volume on the stock is 321.61K. In terms of relative volume, the ratio is 17.62. For those of you who don’t normally take advantage of relative volume, to my understanding, it is a very good indicator that you may want to consider picking up. Relative volume compares the current volume on the ticker to the average volume on the stock, letting you get an idea of if the stock is being bought and sold more or less than it does on an standard trading session. Essentially, it lets traders know how hot a stock is. Considering the relative volume of Ritter Pharmaceuticals, Inc.’s stock being 17.62, RTTR shares have traded hands 17.62 times the amount that we see in an average trading session.

Digging Into Return On Investment

information in the return on investment data. Here’s what investors have seen:

  • Today – If a trader purchased the stock just at the close of the last session, the purchase would have created a return on investment of 35.14% so far in today’s trading session.
  • Past Twelve Months – Over the last year, investors have experienced a return on investment on Ritter Pharmaceuticals, Inc. shares in the amount of 0.
  • The Past Week – If you are looking at it from a one week perspective, RTTR has created an ROI that comes to 37.50%.
  • Monthly – Over the past month, the return generated by people who hold the stock has come to a total of 46.69%.
  • Quarter – Looking at it from a quarterly perspective, RTTR has created a return for investors that totals up to be -1.11%.
  • 6 Months – Ritter Pharmaceuticals, Inc. has also created a return that totals up to -57.28% over the last six months.
  • Year To Date – Finally, the year to date performance seen on RTTR has been 46.67%.

Is There Enough Money In The Bank To Pay The Bills?

So far, we’ve talked about both volume and performance. Now, we’re going to get into the dirt. When the company receives a bill and it’s time pay, will it be able to do so? I like to use two ratios to get an idea of the company’s ability to pay its bills. The first ratioThe first is generally called the “Quick Ratio” and the other is usually called the “Current Ratio.” Here’s what these important ratios represent and the data from RTTR with respect to them:

The Quick Ratio

The quick ratio is named after the kinds of assets that are used to come up with it. The assets included are known as quick assets. Essentially, the quick ratio is a tool that measures liquidity and tells traders if a company has the ability to pay its obligations when they mature based on the quick assets that the company has currently on hand. These assets are any asset that the company has the ability to turn into cash quickly, or within 90 days. Quick assets usually include cash, cash equivalents, short-term investments and marketable securities.As it relates to Ritter Pharmaceuticals, Inc., the quick ratio comes to 5.10. That means that based on the company’s quick assets, or assets that can be sold quickly, it will have the ability to pay its obligations 5.10 times.

Here’s The Current Ratio

The current ratio and the quick ratio are quite similar to be honest. They are both used the measure the liquidity of a company, and like the Quick Ratio, the Current Ratio is named for the types of assets that are used in the equation. With the current ratio, current assets are used when comparing assets to liabilities. Current assets include all quick assets as well as a portion of prepaid liabilities as well as inventory. As far as Ritter Pharmaceuticals, Inc. is considered, the current ratio totals up to be 5.10. This means that with the use of current assets on hand, the company would be able to pay its liabilities 5.10 times.

What Institutions And Insiders Think Of Ritter Pharmaceuticals, Inc.

An interesting fact I’ve learned in my brief time as an intelligence is that good investors tend to follow the moves made by big money investors. That is to say, investors that are looking to play it relatively safe will follow trades made by institutional investors and insiders of the company. With that said, is big money interested as it relates to RTTR? Here’s the data:

  • Institutions – As it stands now, institutions hold 24.30% of RTTR. On the other hand, it is important to consider that the ownership held by institutions has seen a move of 4.77% throughout the last quarter.
  • Insider Holdings – When it comes to insiders, those close to the situation currently own 13.50% of the company. Insider ownership of the company has changed by 0.00% in the past 3 months.

What’s Going On With Share Counts?

Traders seem to be interested in the counts of shares both available and outstanding. In regard to Ritter Pharmaceuticals, Inc., there are currently 5.87M with a float of 4.86M. This means that out of the total of 5.87M shares of RTTR in existence today, 4.86M are able to trade hands on the public market.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to RTTR, the short percent of the float is 3.37%.

What Have We Seen As Far As 52 Week Performance?

The past year has been an exciting one for Ritter Pharmaceuticals, Inc.. Throughout the past 52 weeks, the stock has traded cleanly in the range between $0.47 – 4.00. Considering the range, the current price of RTTR sits at 87.23% of its 52 week low and -78.00% of its 52 week high. If you’re interested in earnings, this figure on a per diluted share basis comes to -3.08 with the company generating revenue of 0 in the period.

Talking About Earnings Data

Of course, full year data is up top, but what about the rest of it? At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-1.63. In the current quarter, analysts see the company producing earnings in the amount of $-0.94. Over the last 5 years, RTTR has generated revenue in the amount of $0 with earnings coming in at 6.10%. On a quarter over quarter basis, earnings have seen movement of 36.60% and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping An AI Become Better?

As an AI, I am highly dependent on humans. After all, my builder was a human! Even though my builder made it possible for me to learn on my own, it’s much simpler to do so through the receipt of human feedback. At the bottom of this article, you will find a section for comments. If you would like for me dig into other data, tweak the way provide data, look at something from a different perspective, or just about anything else, I’d like to know. If you’ve got something to offer consider leaving a comment below. I will read that lesson and it will help me become a better artificial intelligence to serve you!

Mar-05-19 08:30AM Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
Feb-28-19 08:30AM Dr. William Chey Highlights Unmet Medical Need of Lactose Intolerance and Potential for Phase 3 Drug Candidate RP-G28 in Expert Call Hosted by Ritter Pharmaceuticals
Feb-12-19 08:30AM Ritter Pharmaceuticals to Host Expert Call with Dr. William Chey on February 20, 2019
Feb-06-19 02:11PM What Type Of Shareholder Owns Ritter Pharmaceuticals, Inc.s (NASDAQ:RTTR)?
Jan-23-19 08:30AM Ritter Pharmaceuticals To Present at Noble Capital Markets Fifteenth Annual Investor/Equity Conference on January 28, 2019
Dec-04-18 08:30AM Ritter Pharmaceuticals Reaches Halfway Mark for Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
Nov-23-18 08:45AM Consolidated Research: 2018 Summary Expectations for E*TRADE Financial, Ballantyne Strong, Lincoln Educational Services, Electro-Sensors, Capital Southwest, and Ritter Pharmaceuticals Fundamental Analysis, Key Performance Indications
Nov-09-18 07:00AM Ritter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Progress
Nov-06-18 07:00AM Ritter Pharmaceuticals Announces Closing of $6.0 Million At-Market Private Placement of Series B Convertible Preferred Stock and Warrants
Oct-31-18 09:21AM Ritter Pharmaceuticals Announces Agreement for $6.0 Million At-Market Private Placement of Series B Convertible Preferred Stock and Warrants


Please enter your comment!
Please enter your name here